Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cytovance Appoints COO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Cytovance Appoints COO

Wuchterl to oversee R&D services, manufacturing, engineering, and program management

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Donald Wuchterl has been promoted to chief operating officer at Cytovance Biologics. Mr. Wuchterl will oversee Cytovance’s R&D services, manufacturing and warehouse, facilities, engineering, and program management functions. Mr. Wuchterl joined the company in July of 2012 as senior vice president of manufacturing operations. 

Mr. Wuchterl has played a major leadership role in organizational improvements and Cytovance’s growth and expansion. This includes the construction and qualification/validation of several new production suites as well as a new Greenfield manufacturing and GMP warehousing facility that will greatly increase the company’s scale, service offerings, and technical capabilities.

“I have had the distinct pleasure of knowing Don for many years and feel he is the ideal candidate for this position. His knowledge and experience with both clinical and commercial biologics manufacturing, along with his years of working in the design and validation of biologics facilities makes him an invaluable asset to Cytovance’s Leadership team,” said chief executive officer Darren Head.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics